A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries

References

• Adiga, U., & Adiga, S. (2018). A cost of illness study of Type 2 diabetes mellitus in Mangalore, Karnataka, India. Asian Journal of Pharmaceutical and Clinical Research, 11(11), 139–145. https://doi.org/10.22159/ajpcr.2018.v11i11.27558
   Google Scholar
• Afroz, A., et al. (2019). Type 2 diabetes mellitus in Bangladesh: A prevalence based cost-of-illness study. BMC Health Services Research, 19(1), 1–12. https://doi.org/10.1186/s12913-019-4440-3
   PubMed Web of Science ®Google Scholar
• Afroz, A., Alramadan, M. J., Hossain, M. N., Romero, L., Alam, K., Magliano, D. J., & Billah, B., et al. (2018). Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: A systematic review. BMC Health Services Research, 18(1), 1–10. https://doi.org/10.1186/s12913-018-3772-8
   PubMedGoogle Scholar
• Akari, S., Mateti, U. V., & Kunduru, B. R. (2013). Health-care cost of diabetes in South India: A cost of illness study. Journal of Research in Pharmacy Practice, 2(3), 114. https://doi.org/10.4103/2279-042X.122382
   PubMedGoogle Scholar
• Akhtar, S., et al. (2019). Diabetes in Pakistan: A systematic review and meta-analysis. Pakistan Journal of Medical Sciences, 35(4), 1173. https://doi.org/10.12669/pjms.35.4.194
   PubMed Web of Science ®Google Scholar
• Akobundu, E., et al. (2006). Cost-of-illness studies: A review of current methods. Pharmacoeconomics, 24(9), 869–890. https://doi.org/10.2165/00019053-200624090-00005
   PubMed Web of Science ®Google Scholar
• Alzaid, A., et al. (2021). Burden of disease and costs associated with type 2 diabetes in emerging and established markets: Systematic review analyses. Expert Review of Pharmacoeconomics & Outcomes Research, 21(4), 785–798. https://doi.org/10.1080/14737167.2020.1782748
   PubMed Web of Science ®Google Scholar
• Alzubaidi, H., et al. (2022). The relationship between diabetes distress, medication taking, glycaemic control and self-management. International Journal of Clinical Pharmacy, 44(1), 127–137. https://doi.org/10.1007/s11096-021-01322-2
   PubMed Web of Science ®Google Scholar
• Amon, S. K., & Aikins, M. K. S. (2017). Economic burden of type 2 diabetes mellitus complications among patients in the eastern region of Ghana: A descriptive cross-sectional cost-of-illness study. Diabetes Manag, 7(5), 367–376.
   Google Scholar
• Amos, A. F., McCarty, D. J., & Zimmet, P. (1997). The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabetic Medicine, 14(S5), S7–S85. https://doi.org/10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.0.CO;2-R
   PubMed Web of Science ®Google Scholar
• Andersson, E., et al. (2020). Costs of diabetes complications: Hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden. Diabetologia, 63(12), 2582–2594. https://doi.org/10.1007/s00125-020-05277-3
   PubMed Web of Science ®Google Scholar
• Anja, B., & Laura, R. (2017). The cost of diabetes in Canada over 10 years: Applying attributable health care costs to a diabetes incidence prediction model. Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice, 37(2), 49.
   PubMed Web of Science ®Google Scholar
• Arffman, M., et al. (2020). FinDM database on diabetes in Finland.
   Google Scholar
• Association, A. D. (2013). Economic costs of diabetes in the US in 2012. Diabetes Care, 36(4), 1033–1046. https://doi.org/10.2337/dc12-2625
   PubMed Web of Science ®Google Scholar
• Bahari, N. I., et al. (2023). Issues and challenges in the primary prevention of Type 2 diabetes mellitus: A systematic review. Journal of Prevention, 44(1), 105–125. https://doi.org/10.1007/s10935-022-00707-x
   Google Scholar
• Bahia, L. R., et al. (2019). Economic burden of diabetes in Brazil in 2014. Diabetology & Metabolic Syndrome, 11(1), 1–9. https://doi.org/10.1186/s13098-019-0448-4
   PubMedGoogle Scholar
• Bao, X., et al. (2017). Hospitalization costs and complications in hospitalized patients with type 2 diabetes mellitus in Beijing, China: 中国北京市 2 型糖尿病住院患者费用与并发症的关系分析. Journal of Diabetes, 9(4), 405–411. https://doi.org/10.1111/1753-0407.12428
   PubMed Web of Science ®Google Scholar
• Barquera, S., et al. (2013). Diabetes in Mexico: Cost and management of diabetes and its complications and challenges for health policy. Globalization and Health, 9(1), 1–9. https://doi.org/10.1186/1744-8603-9-3
   PubMedGoogle Scholar
• Barua, L., et al. (2021). Health-related quality of life and its predictors among the type 2 diabetes population of Bangladesh: A nation-wide cross-sectional study. Journal of Diabetes Investigation, 12(2), 277–285. https://doi.org/10.1111/jdi.13331
   PubMed Web of Science ®Google Scholar
• Bermudez-Tamayo, C., et al. (2017). Direct and indirect costs of diabetes mellitus in Mali: A case-control study. PLoS One, 12(5), e0176128. https://doi.org/10.1371/journal.pone.0176128
   PubMed Web of Science ®Google Scholar
• Bloom, D. E., et al. (2014). The macroeconomic impact of non-communicable diseases in China and India: Estimates, projections, and comparisons. The Journal of the Economics of Ageing, 4, 100–111. https://doi.org/10.1016/j.jeoa.2014.08.003
   Google Scholar
• Bommer, C., et al. (2017). The global economic burden of diabetes in adults aged 20–79 years: A cost-of-illness study. The Lancet Diabetes & Endocrinology, 5(6), 423–430. https://doi.org/10.1016/S2213-8587(17)30097-9
   PubMed Web of Science ®Google Scholar
• Bommer, C., et al. (2018). Global economic burden of diabetes in adults: Projections from 2015 to 2030. Diabetes Care, 41(5), 963–970. https://doi.org/10.2337/dc17-1962
   PubMed Web of Science ®Google Scholar
• Borges, N. B., Ferraz, M. B., & Chacra, A. R. (2014). The cost of type 2 diabetes in Brazil: Evaluation of a diabetes care center in the city of São Paulo, Brazil. Diabetology & Metabolic Syndrome, 6(1), 1–10. https://doi.org/10.1186/1758-5996-6-122
   PubMedGoogle Scholar
• Boyanov, M., et al. (2011). PDB29 modeling the impact of enhanced treatment of Type 2 diabetes mellitus in Bulgaria. Value in Health, 14(7), A476–A477. https://doi.org/10.1016/j.jval.2011.08.1332
   Web of Science ®Google Scholar
• Bruno, G., et al. (2012). Direct costs in diabetic and non diabetic people: The population-based Turin study, Italy. Nutrition, Metabolism and Cardiovascular Diseases, 22(8), 684–690. https://doi.org/10.1016/j.numecd.2011.04.007
   PubMed Web of Science ®Google Scholar
• Butt, M. D., et al. (2022). Cost of illness analysis of type 2 diabetes mellitus: The findings from a lower-middle income country. International Journal of Environmental Research and Public Health, 19(19), 12611. https://doi.org/10.3390/ijerph191912611
   PubMed Web of Science ®Google Scholar
• Cannon, A., et al. (2018). Burden of illness in type 2 diabetes mellitus. Journal of Managed Care & Specialty Pharmacy, 24(9-a Suppl), S5–S13. https://doi.org/10.18553/jmcp.2018.24.9-a.s5
   PubMed Web of Science ®Google Scholar
• Chatterjee, S., et al. (2011). Cost of diabetes and its complications in Thailand: A complete picture of economic burden. Health & Social Care in the Community, 19(3), 289–298. https://doi.org/10.1111/j.1365-2524.2010.00981.x
   PubMed Web of Science ®Google Scholar
• Chen, Y.-C., et al. (2016). Impact of pay-for-performance on mortality in diabetes patients in Taiwan: A population-based study. Medicine, 95(27), e4197. https://doi.org/10.1097/MD.0000000000004197
   PubMed Web of Science ®Google Scholar
• Chow, C. K., et al. (2018). Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: A prospective epidemiological study. The Lancet Diabetes & Endocrinology, 6(10), 798–808. https://doi.org/10.1016/S2213-8587(18)30233-X
   PubMed Web of Science ®Google Scholar
• Dahal, P. K., et al. (2022). Economic evaluation of health behavior interventions to prevent and manage Type 2 diabetes mellitus in Asia: A systematic review of randomized controlled trials. International Journal of Environmental Research and Public Health, 19(17), 10799. https://doi.org/10.3390/ijerph191710799
   PubMed Web of Science ®Google Scholar
• Davari, M., Boroumand, Z., Amini, M., Aslani, A., & Hosseini, M., et al. (2016). The direct medical costs of outpatient cares of type 2 diabetes in Iran: A retrospective study. International Journal of Preventive Medicine, 7, 72. https://doi.org/10.4103/2008-7802.181758
   PubMedGoogle Scholar
• Dedov, I. I., et al. (2018). Cost-of-Illness analysis of type 2 diabetes mellitus in the Russian federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM). Diabetes mellitus, 20(6), 403–419. https://doi.org/10.14341/DM9278
   Google Scholar
• de Lagasnerie, G., et al. (2018). The economic burden of diabetes to French national health insurance: A new cost-of-illness method based on a combined medicalized and incremental approach. The European Journal of Health Economics, 19(2), 189–201. https://doi.org/10.1007/s10198-017-0873-y
   PubMed Web of Science ®Google Scholar
• Elgart, J. F., et al. (2014). Direct and indirect costs associated to type 2 diabetes and its complications measured in a social security institution of Argentina. International Journal of Public Health, 59(5), 851–857. https://doi.org/10.1007/s00038-014-0604-4
   PubMed Web of Science ®Google Scholar
• Erzse, A., et al. (2019). The direct medical cost of type 2 diabetes mellitus in South Africa: A cost of illness study. Global Health Action, 12(1), 1636611. https://doi.org/10.1080/16549716.2019.1636611
   PubMed Web of Science ®Google Scholar
• Ettaro, L., et al. (2004). Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics, 22(3), 149–164. https://doi.org/10.2165/00019053-200422030-00002
   PubMed Web of Science ®Google Scholar
• Fadare, J., Olamoyegun, M., & Gbadegesin, B. (2015). Medication adherence and direct treatment cost among diabetes patients attending a tertiary healthcare facility in Ogbomosho, Nigeria. Malawi Medical Journal, 27(2), 65–70. https://doi.org/10.4314/mmj.v27i2.7
   PubMed Web of Science ®Google Scholar
• Flood, D., et al. (2021). The state of diabetes treatment coverage in 55 low-income and middle-income countries: A cross-sectional study of nationally representative, individual-level data in 680 102 adults. The Lancet Healthy Longevity, 2(6), e340–e351. https://doi.org/10.1016/S2666-7568(21)00089-1
   PubMedGoogle Scholar
• García, A. L., et al. (2015). The cost of polypharmacy in patients with type 2 diabetes mellitus. Revista Médica de Chile, 143(5), 606–611. https://doi.org/10.4067/S0034-98872015000500008
   PubMed Web of Science ®Google Scholar
• Gillani, A. H., et al. (2018). Direct and indirect cost of diabetes care among patients with type 2 diabetes in private clinics: A multicenter study in Punjab, Pakistan. Expert Review of Pharmacoeconomics & Outcomes Research, 18(6), 647–653. https://doi.org/10.1080/14737167.2018.1503953
   PubMed Web of Science ®Google Scholar
• Gutierrez, J. P., Garcia-Saiso, S., & Aracena, B. M. (2018). Mexico’s household health expenditure on diabetes and hypertension: What is the additional financial burden? PLoS One, 13(7), e0201333. https://doi.org/10.1371/journal.pone.0201333
   PubMed Web of Science ®Google Scholar
• Gyawali, B., et al. (2015). Prevalence of type 2 diabetes in Nepal: A systematic review and meta-analysis from 2000 to 2014. Global Health Action, 8(1), 29088. https://doi.org/10.3402/gha.v8.29088
   PubMed Web of Science ®Google Scholar
• Ha, J., Stocker, M. M., & Yilmazkuday, H. (2020). Inflation and exchange rate pass-through. Journal of International Money and Finance, 105, 102187. https://doi.org/10.1016/j.jimonfin.2020.102187
   Web of Science ®Google Scholar
• Halim, M., & Halim, A. (2019). The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(2), 1165–1172. https://doi.org/10.1016/j.dsx.2019.01.040
   PubMed Web of Science ®Google Scholar
• Hex, N., et al. (2012). Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabetic Medicine, 29(7), 855–862. https://doi.org/10.1111/j.1464-5491.2012.03698.x
   PubMed Web of Science ®Google Scholar
• Huang, Y., et al. (2016). Economic burden in Chinese patients with diabetes mellitus using electronic insurance claims data. PloS One, 11(8), e0159297.
   PubMed Web of Science ®Google Scholar
• Hussain, M., et al. (2014). Direct cost of treatment of diabetes mellitus type 2 in Pakistan. International Journal of Pharmacy and Pharmaceutical Sciences, 6(11), 261–264.
   Google Scholar
• Ibrahim, W. N. (2014). Comparison of type II diabetes mellitus outpatient care cost by level of care. BMC Public Health, 14(1), 1–1. https://doi.org/10.1186/1471-2458-14-S1-P1
   PubMedGoogle Scholar
• Ismail, A., et al. (2017). Economic burden of managing type 2 diabetes mellitus: Analysis from a teaching hospital in Malaysia. Indian Journal of Public Health, 61(4), 243–247. https://doi.org/10.4103/ijph.IJPH_24_16
   PubMedGoogle Scholar
• Jacobs, E., et al. (2017). Healthcare costs of Type 2 diabetes in Germany. Diabetic Medicine, 34(6), 855–861. https://doi.org/10.1111/dme.13336
   PubMed Web of Science ®Google Scholar
• Javanbakht, M., et al. (2011). Cost-of-illness analysis of type 2 diabetes mellitus in Iran. PLoS One, 6(10), e26864. https://doi.org/10.1371/journal.pone.0026864
   PubMed Web of Science ®Google Scholar
• Karachaliou, F., Athanasakis, K., Tsentidis, C., Kitra, M., Kyriopoulos, J., & Karavanaki, K., et al. (2014). Direct costs of diabetes care in pediatric patients with type 1 diabetes in Greece. Journal of Diabetes Mellitus, 40(03), 209–215. https://doi.org/10.4236/jdm.2014.43030
   Google Scholar
• Katam, K. K., et al. (2016). High direct costs of medical care in patients with type 1 diabetes attending a referral clinic in a government-funded hospital in northern India. The National Medical Journal of India, 29(2), 64.
   PubMed Web of Science ®Google Scholar
• Kattel, V., et al. (2019). Cost of illness study of regular Out patient department diabetic in a Low income country: A cross sectional study. Journal of Diabetes and Endocrinology Association of Nepal, 3(1), 16–25. https://doi.org/10.3126/jdean.v3i1.24060
   Google Scholar
• Khaledi, M., et al. (2019). The prevalence of comorbid depression in patients with type 2 diabetes: An updated systematic review and meta-analysis on huge number of observational studies. Acta Diabetologica, 56(6), 631–650. https://doi.org/10.1007/s00592-019-01295-9
   PubMed Web of Science ®Google Scholar
• Khan, M. A. B., et al. (2020). Epidemiology of type 2 diabetes–global burden of disease and forecasted trends. Journal of Epidemiology and Global Health, 10(1), 107. https://doi.org/10.2991/jegh.k.191028.001
   PubMed Web of Science ®Google Scholar
• Kleinstäuber, M., et al. (1996). Cochrane database of systematic reviews.
   Google Scholar
• Konttila, J., et al. (2019). Healthcare professionals’ competence in digitalisation: A systematic review. Journal of Clinical Nursing, 28(5–6), 745–761. https://doi.org/10.1111/jocn.14710
   PubMed Web of Science ®Google Scholar
• Köster, I., et al. (2011). Direct costs of diabetes mellitus in Germany–CoDiM 2000–2007. Experimental and Clinical Endocrinology & Diabetes, 119(06), 377–385. https://doi.org/10.1055/s-0030-1269847
   PubMedGoogle Scholar
• Larg, A., & Moss, J. R. (2011). Cost-of-illness studies: A guide to critical evaluation. Pharmacoeconomics, 29(8), 653–671. https://doi.org/10.2165/11588380-000000000-00000
   PubMed Web of Science ®Google Scholar
• Le, N. T. D., Dinh Pham, L., & Quang Vo, T. (2017). Type 2 diabetes in Vietnam: A cross-sectional, prevalence-based cost-of-illness study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 10, 363–374. https://doi.org/10.2147/DMSO.S145152
   PubMed Web of Science ®Google Scholar
• Leśniowska, J., et al. (2014). Costs of diabetes and its complications in Poland. The European Journal of Health Economics, 15(6), 653–660. https://doi.org/10.1007/s10198-013-0513-0
   PubMed Web of Science ®Google Scholar
• Lesniowska, J., & Skrzekowska-Baran, I. (2011). PDB32 cost of diabetes and its complications in Poland: Preliminary results. Value in Health, 14(7), A477. https://doi.org/10.1016/j.jval.2011.08.1335
   Web of Science ®Google Scholar
• Li, M.-Z., Su, L., Liang, B.-Y., Tan, J.-J., Chen, Q., Long, J.X., Xie, J.J., Wu, G.-L., Yan, Y., Guo, X.-J., & Gu, L. (2013). Trends in prevalence, awareness, treatment, and control of diabetes mellitus in mainland China from 1979 to 2012. International Journal of Endocrinology, 2013, 753150, 14pages. https://doi.org/10.1155/2013/753150
   PubMed Web of Science ®Google Scholar
• Mapa-Tassou, C., et al. (2019). Economic impact of diabetes in Africa. Current Diabetes Reports, 19(2), 1–8. https://doi.org/10.1007/s11892-019-1124-7
   PubMed Web of Science ®Google Scholar
• Marcellusi, A., et al. (2016). The direct and indirect cost of diabetes in Italy: A prevalence probabilistic approach. The European Journal of Health Economics, 17(2), 139–147. https://doi.org/10.1007/s10198-014-0660-y
   PubMed Web of Science ®Google Scholar
• Moher, D., et al. (2010). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. International Journal of Surgery, 8(5), 336–341. https://doi.org/10.1016/j.ijsu.2010.02.007
   PubMed Web of Science ®Google Scholar
• Mokdad, A. H., et al. (2015). Cost of diabetes in the kingdom of Saudi arabia, 2014. Journal of Diabetes & Metabolism, 6(575), 2.
   Google Scholar
• Moucheraud, C., et al. (2019). The costs of diabetes treatment in low-and middle-income countries: A systematic review. BMJ Global Health, 4(1), e001258. https://doi.org/10.1136/bmjgh-2018-001258
   PubMed Web of Science ®Google Scholar
• Murray, C. J., Lopez, A. D., & W.H. Organization. (1994). Global comparative assessments in the health sector:disease burden, expenditures and intervention packages.
   Google Scholar
• Ng, C. S., et al. (2014). Cost-of-illness studies of diabetes mellitus: A systematic review. Diabetes Research and Clinical Practice, 105(2), 151–163. https://doi.org/10.1016/j.diabres.2014.03.020
   PubMed Web of Science ®Google Scholar
• Palmer, J., et al. (2012). PDB18 direct medical costs of diabetes mellitus in China: Annual cost of illness and long-term projections using a validated diabetes model. Value in Health, 15(7), A662. https://doi.org/10.1016/j.jval.2012.08.349
   Google Scholar
• Papanicolas, I., Woskie, L. R., & Jha, A. K. (2018). Health care spending in the United States and other high-income countries. Jama, 319(10), 1024–1039. https://doi.org/10.1001/jama.2018.1150
   PubMed Web of Science ®Google Scholar
• Patty, Y. F. P. P., & Nita, Y. (2022). IAI SPECIAL EDITION: Cost of illness analysis of diabetes mellitus with complications in one hospital in Surabaya. Pharmacy Education, 22(2), 254–258. https://doi.org/10.46542/pe.2022.222.254258
   Web of Science ®Google Scholar
• Quaye, E., Akweongo, P., & Aikins, M. (2011). PDB33 cost of diabetes management to Cocoa clinics in Ghana. Value in Health, 14(7), A477. https://doi.org/10.1016/j.jval.2011.08.1336
   Web of Science ®Google Scholar
• Rice, D. P. (1994). Cost-of-illness studies: Fact or fiction? The Lancet, 344(8936), 1519–1520. https://doi.org/10.1016/S0140-6736(94)90342-5
   PubMed Web of Science ®Google Scholar
• Riewpaiboon, A., Chatterjee, S., & Piyauthakit, P. (2011). Cost analysis for efficient management: Diabetes treatment at a public district hospital in Thailand. International Journal of Pharmacy Practice, 19(5), 342–349. https://doi.org/10.1111/j.2042-7174.2011.00131.x
   PubMedGoogle Scholar
• Sathyanath, S., Kundapur, R., Deepthi, R., Poojary, S. N., Rai, S., Modi, B., & Saxena, D. (2022). An economic evaluation of diabetes mellitus in India: A systematic review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 16(11), 02641. https://doi.org/10.1016/j.dsx.2022.102641
   Web of Science ®Google Scholar
• Sepanlou, S. G., et al. (2017). Disability-Adjusted Life-Years (DALYs) for 315 diseases and injuries and Healthy Life Expectancy (HALE) in Iran and its neighboring countries, 1990–2015: Findings from global burden of disease study 2015. Archives of Iranian Medicine, 20(7), 403–418.
   PubMed Web of Science ®Google Scholar
• Seuring, T., Archangelidi, O., & Suhrcke, M. (2015). The economic costs of type 2 diabetes: A global systematic review. Pharmacoeconomics, 33(8), 811–831. https://doi.org/10.1007/s40273-015-0268-9
   PubMed Web of Science ®Google Scholar
• Shetty, A., et al. (2021). Health-related quality of life among people with type 2 diabetes mellitus–A multicentre study in Bangladesh. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15(5), 102255. https://doi.org/10.1016/j.dsx.2021.102255
   PubMed Web of Science ®Google Scholar
• Simon, P., et al. (2019). Quality of life in diabetics with different complications: A cross-sectional study with patients visiting a hospital on an outpatient basis. Hamdan Medical Journal, 12(4), 195. https://doi.org/10.4103/HMJ.HMJ_15_19
   Google Scholar
• Sortsoe, C., et al. (2016). Societal costs of diabetes mellitus in Denmark. Diabetic Medicine, 33(7), 877–885. https://doi.org/10.1111/dme.12965
   PubMed Web of Science ®Google Scholar
• Suleiman, I. A., & Festus, J. A. (2015). Cost of illness among diabetes mellitus patients in Niger Delta, Nigeria. Journal of Pharmaceutical Health Services Research, 6(1), 53–60.
   Google Scholar
• Sun, H., et al. (2022). IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice, 183, 109119. https://doi.org/10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• Taha, M. B., et al. (2022). Cost-related medication nonadherence in adults with diabetes in the UnitedStates: The national health interview survey 2013–2018. Diabetes Care, 45(3), 594–603. https://doi.org/10.2337/dc21-1757
   PubMed Web of Science ®Google Scholar
• Tarricone, R. (2006). Cost-of-illness analysis: What room in health economics? Health Policy, 77(1), 51–63. https://doi.org/10.1016/j.healthpol.2005.07.016
   PubMed Web of Science ®Google Scholar
• Tharkar, S., et al. (2010). The socioeconomics of diabetes from a developing country: A population based cost of illness study. Diabetes Research and Clinical Practice, 89(3), 334–340. https://doi.org/10.1016/j.diabres.2010.05.009
   PubMed Web of Science ®Google Scholar
• Todorova, L., et al. (2012). PDB21 direct medical costs of diabetes-related complications in India. Value in Health, 15(7), A662.
   Web of Science ®Google Scholar
• Toscano, C. M., et al. (2018). Annual direct medical costs of diabetic foot disease in Brazil: A cost of illness study. International Journal of Environmental Research and Public Health, 15(1), 89. https://doi.org/10.3390/ijerph15010089
   PubMed Web of Science ®Google Scholar
• Ulrich, S., et al. (2016). Cost burden of type 2 diabetes in Germany: Results from the population-based KORA studies. BMJ Open, 6(11), e012527. https://doi.org/10.1136/bmjopen-2016-012527
   PubMed Web of Science ®Google Scholar
• Win Tin, S. T., et al. (2015). Counting the cost of diabetes in the Solomon Islands and Nauru. PLoS One, 10(12), e0145603. https://doi.org/10.1371/journal.pone.0145603
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2022). Diabetes Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes.
   Google Scholar
• Ying, A. K., et al. (2011). Predictors of direct costs of diabetes care in pediatric patients with type 1 diabetes. Pediatric Diabetes, 12(3pt1), 177–182. https://doi.org/10.1111/j.1399-5448.2010.00680.x
   PubMedGoogle Scholar
• Zhang, P., et al. (2010). Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Research and Clinical Practice, 87(3), 293–301. https://doi.org/10.1016/j.diabres.2010.01.026
   PubMed Web of Science ®Google Scholar
• Zhuo, X., et al. (2014). The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes Care, 37(9), 2557–2564. https://doi.org/10.2337/dc13-2484
   PubMed Web of Science ®Google Scholar